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Abstract 
Biotin-dependent enzymes catalyze carboxylation, decarboxylation and transcarboxylation reactions that 
participate in the primary metabolism of a wide range of organisms. In all cases, the overall reaction proceeds 
via two half reactions that take place in physically distinct active sites. In the first half-reaction, a carboxyl group 
is transferred to the 1-N′ of a covalently tethered biotin cofactor. The tethered carboxybiotin intermediate 
subsequently translocates to a second active site where the carboxyl group is either transferred to an acceptor 
substrate or, in some bacteria and archaea, is decarboxylated to biotin and CO2 in order to power the export of 
sodium ions from the cytoplasm. A homologous carboxyltransferase domain is found in three enzymes that 
catalyze diverse overall reactions: carbon fixation by pyruvate carboxylase, decarboxylation and sodium 
transport by the biotin-dependent oxaloacetate decarboxylase complex, and transcarboxylation by 
transcarboxylase from Propionibacterium shermanii. Over the past several years, structural data have emerged 
which have greatly advanced the mechanistic description of these enzymes. This review assembles a uniform 
description of the carboxyltransferase domain structure and catalytic mechanism from recent studies of 
pyruvate carboxylase, oxaloacetate decarboxylase and transcarboxylase, three enzymes that utilize an 
analogous carboxyltransferase domain to catalyze the biotin-dependent decarboxylation of oxaloacetate. 
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Introduction 
In 1933, Burk and colleagues described an accessory factor isolated from egg yolk that was essential for the 
growth of the nitrogen-fixing bacterium, Rhizobium [1]. Three years later, Kögl and Tonnis isolated a crystalline 
‘Bios’ factor from duck egg yolks that they called biotin [2]. Shortly thereafter, biotin was recognized as an 
essential growth factor common to bacteria, yeast and mammals (reviewed in [3]). The structure of biotin was 
soon chemically deduced (Fig. 1; [4]) and it was shown to be involved in carboxylation reactions, providing a clue 
into its role in cellular physiology [5]. Eventually, biotin was found to be covalently tethered to and necessary 
for catalysis in acetyl coenzyme A (CoA)1 carboxylase [6]. This critical observation established a biological role for 
biotin in CO2 fixation and resulted in the discovery of a family of enzymes known today as the biotin-dependent 
enzymes. 
 
Fig. 1. Chemical structure of biotin and N-carboxybiotin. (1) Biotin, also known as vitamin H, vitamin 
B7 or coenzyme R, is composed of a valerate side chain tethered to a bicyclic ring. The bicyclic ring consists of a 
ureido ring fused to a tetrahydrothiophene ring. (2) N-carboxybiotin is the reaction intermediate for all biotin-
dependent enzymes. Biotin is carboxylated at the N-1 position. 
 
In recent years, the description of structure and function in the biotin-dependent enzymes has advanced 
considerably, primarily as a result of an influx of new X-ray crystal structures. Two recent reviews [7], [8] have 
summarized these structural advances, particularly in the Class I biotin-dependent enzymes, and the reader is 
referred to these sources for a complete and recent description of the carboxylase class of biotin-dependent 
enzymes. This review focuses, instead, on the structure and function of the carboxyltransferase domain from 
three enzymes that encompass the three classes of the biotin-dependent family: pyruvate carboxylase, 
oxaloacetate decarboxylase and transcarboxylase. These three enzymes catalyze very different overall reactions, 
but structural and kinetic data compiled over the past 10 years have provided significant insights into common 
active site features, shared aspects of chemical mechanism and similarities in the interactions between the 
carboxyltransferase domain, the biotin cofactor and associating functional domains. 
Biotin-dependent enzymes 
The biotin-dependent enzymes are present across all three domains of life, and phylogenetic analyses of the 
individual domains suggest an ancient evolutionary origin [9]. These enzymes are composed of two distinct 
active sites, with a covalently tethered biotin cofactor traveling between active sites via a so-called swinging-arm 
mechanism [10]. All enzymes in this family must coordinate the biotin-dependent transfer of a carboxyl moiety 
between remote active sites by way of two independent half-reactions. As such, they require multiple catalytic 
domains to accomplish catalysis. 
Biotin serves as the conduit for carboxyl transfer and is carboxylated at the 1’-N position in the first active site 
(Fig. 1; [11], [12], [13]). The resulting carboxybiotin product is relatively stable, with a half-life exceeding 100 min 
at pH 8 [14]. The stability of 1’-N-carboxybiotin is critical, since energy is expended in carboxylating biotin and 
because carboxybiotin must physically translocate to a second active site prior to transferring the carboxyl 
moiety to an acceptor substrate. 
The biotin cofactor is covalently attached, via an amide linkage, to the ε-amino group of a specific, conserved 
lysine in the biotin carboxyl carrier protein (BCCP) domain by the enzyme biotin protein ligase [15]. Several NMR 
and X-ray crystal structures of the BCCP domain reveal two sets of four antiparallel β-strands arranged around 
an approximate twofold axis [16], [17], [18], [19]. The site of biotinylation is located on a hairpin turn that 
connects two β-strands near the C-terminal end of the domain. In most cases, the modified lysine residue is 
bracketed within a conserved sequence consisting of Ala–Met–Lys–Met. In pyruvate carboxylase and 
transcarboxylase, this identity extends to Ala–Met–Lys–Met–Glu–Thr. The BCCP domain physically translocates 
between catalytic domains and assists in inserting biotin into the individual active sites. The primary sequence 
and tertiary structure for the C-terminal ∼80 amino acids of the BCCP domain is conserved for all enzymes 
within the family, suggesting that they are descended from a common ancestor [20]. In Escherichia coli acetyl-
CoA carboxylase, however, the BCCP subunit includes an additional N-terminal domain of ∼80 amino acids 
which may serve to impede the catalytic half-reactions prior to assembly of the complete enzyme 
complex [21], [22]. 
The biotin-dependent enzymes are divided into three classes, depending on the overall reaction that they 
catalyze [23]. These are briefly described below. 
Class I – carboxylases 
Class I enzymes are unique within the biotin-dependent family in catalyzing carbon fixation. On the basis of 
chemical reactivity, enzymes involved in carbon fixation would be predicted to favor nucleophilic attack on 
the electrophilic carbon of carbon dioxide. However, at physiological pH and temperature, the concentration of 
dissolved carbon dioxide is twenty times less than bicarbonate ion (10 μM vs. 200 μM), making dissolved carbon 
dioxide availability low by comparison [24]. While there are enzymes that utilize dissolved carbon dioxide as a 
substrate (ribulose-1,5-bisphosphate carboxylase oxygenase, or RuBisCO, is a well-known example), these 
enzymes often suffer from low catalytic activity. Biotin-dependent carboxylases have evolved to effectively 
utilize the more abundant bicarbonate ion for carbon fixation [25], [26]. 
The biotin-dependent carboxylases include pyruvate carboxylase (EC 6.4.1.1), acetyl CoA carboxylase (EC 
6.4.1.2), propionyl CoA carboxylase (EC 6.4.1.3), 3-methylcrotonyl CoA carboxylase (EC 6.4.1.4), geranyl CoA 
carboxylase (EC 6.4.1.5), and urea carboxylase (EC 6.3.4.6) (Fig. 2). All enzymes within this class use a common 
mechanism to carboxylate biotin in the structurally conserved biotin carboxylase (BC) domain. A detailed 
description of the structure and mechanism of the BC domain of the Class I biotin-dependent enzymes is 
provided in a recent review [7]. In the presence of two metal ions, typically Mg2+, ATP is cleaved to activate 
bicarbonate for the subsequent carboxylation of biotin (Fig. 3). The carboxyl moiety is then transferred from 
carboxybiotin to an acceptor substrate in a completely separate carboxyltransferase domain active site. Many of 
these Class I enzymes use a common mechanism and a conserved carboxyltransferase domain to act on a variety 
of thioester substrates [7] but a subset within this class, namely pyruvate carboxylase and urea carboxylase, do 
not act on thioester substrates and their carboxyltransferase domains differ substantially in structure and 
mechanism from each other and from the other enzymes in this class. 
 
Fig. 2. Schematic diagram of the biotin-dependent enzyme family showing the arrangement of catalytic 
and biotin carrier domains. The biotin-dependent enzyme family is subdivided into three classes. The Class I 
carboxylases include pyruvate carboxylase (PC), acetyl-CoA carboxylase (ACC), propionyl-CoA 
carboxylase (PCC), methylcrotonyl-CoA carboxylase (MCC), urea carboxylase (UC) and geranyl-CoA carboxylase 
(not shown). Within this class, both PC and ACC are further subdivided into distinct structural arrangements. As 
described in Section 2.1, the majority of PC enzymes are of the α4 form, with all domains arranged on a single 
polypeptide chain, while a few “subunit type” PC enzymes are composed of separate α- and β-subunits. The ACC 
enzymes of prokaryotic origin are composed of individual subunits while eukaryotic ACC is a multifunctional 
enzyme, with all domains originating from a single polypeptide chain. The Class II decarboxylases include 
oxaloacetate decarboxylase (OADC), methylcrotonyl-CoA decarboxylase (MDC), glutaconyl-CoA decarboxylase 
(GDC) and malonate decarboxylase (not shown). The Class III transcarboxylase consists of a single enzyme, 
transcarboxylase from P. shermanii, described in the section titled "Transcarboxylase". The biotin carboxyl 
carrier protein domain is abbreviated as BCCP. The domains are colored to highlight the homology among the 
individual domains. 
 
Fig. 3. Reaction schemes for the various classes of enzymes within the biotin-dependent enzyme family. The 
general reaction scheme for each biotin-dependent enzyme class is represented. The classes are as follows: (1) 
Class I – carboxylases; (2) Class II – decarboxylases; (3) Class III – transcarboxylase. 
 
Class II – decarboxylases 
Class II enzymes facilitate sodium transport from the cytoplasm to the periplasm in some archaea and anaerobic 
bacteria (Fig. 3). The enzymes included in this class are oxaloacetate decarboxylase (ODC; EC 
4.1.1.3), methylmalonyl CoA decarboxylase (EC 4.1.1.41) and glutaconyl CoA decarboxylase (EC 4.1.1.70) (Fig. 2). 
A biotin-dependent malonate decarboxylase (EC 4.1.1.89) has also been described that proceeds through the 
formation of a malonyl-thioester with a specific acyl carrier protein (ACP) [27], [28]. Decarboxylating the β-keto 
acid of oxaloacetate or the thioester of methylmalonyl CoA, glutaconyl CoA or malonyl-S-ACP affords the 
necessary free energy to pump sodium ions across the lipid bilayer [28], [29], [30], [31], [32]. The resulting 
sodium gradient drives the synthesis of ATP, solute transport and motility in these organisms [33]. This class of 
biotin-dependent enzymes does not transfer a carboxyl moiety to an acceptor substrate. Instead, carboxybiotin 
transits to the membrane-bound β-subunit where it is decarboxylated to biotin and CO2 in a reaction that 
consumes a periplasmic proton and is coupled to Na+ translocation from the cytoplasm to the periplasm. 
Class III – transcarboxylase 
The only enzyme currently described in Class III is transcarboxylase from Propionibacterium shermanii (EC 
2.1.3.1; Fig. 2). Transcarboxylase transfers a carboxyl moiety from methylmalonyl CoA to pyruvate, thus 
resulting in the formation of propionyl CoA and oxaloacetate [34]. Transcarboxylase is unique among the biotin-
dependent enzymes in that it catalyzes carboxyl transfer between two organic molecules. The enzyme utilizes 
two separate carboxyltransferase domains to accomplish this transfer (Fig. 3). 
Biotin-dependent enzymes with oxaloacetate decarboxylation activity 
Biotin-dependent enzymes catalyze carboxylation, decarboxylation and transcarboxylation reactions. Despite 
this diversity of reactions, homologous carboxyltransferase domains appear in enzyme members from all three 
classes. Phylogenetic analysis suggests that the carboxyltransferase domain of pyruvate carboxylase originated 
in an ancestral enzyme that predates the last universal common ancestor and that this domain was 
subsequently usurped for other activities, such as in the oxaloacetate decarboxylase complex of anaerobic 
bacteria [9]. Before describing the detailed structure and mechanism of this carboxyltransferase domain, a brief 
description of pyruvate carboxylase (PC), oxaloacetate decarboxylase (OADC) and transcarboxylase (TC) will 
serve to introduce the general properties and the metabolic context of three biotin-dependent enzymes that 
catalyze distinct overall reactions linked through a common biotin-dependent carboxyltransferase mechanism. 
Pyruvate carboxylase 
Woronick and Johnson first identified an ATP-dependent CO2-fixing system in cell-free extracts from Aspergillus 
niger [35]. This novel reaction was postulated to result in the production of oxaloacetate from pyruvate, ATP and 
CO2. These initial observations swiftly lead to the discovery of an enzyme in avian and bovine liver tissue which 
catalyzes the production of oxaloacetate in an ATP-, CO2-, pyruvate-, Mg2+-, and biotin-dependent manner (Fig. 
31; [36]). This novel enzyme was designated pyruvate carboxylase (PC). To date, PC enzymes have been 
identified across a wide range of organisms including bacteria, fungi, monocot/dicot plants, invertebrates, and 
vertebrates [37], [38]. The structure and mechanism of PC has been the subject of many detailed and 
comprehensive reviews [39], [40], [41], [42] and only a cursory introduction to the metabolic context and the 
overall structure is provided here. 
PC plays an important role in supplying oxaloacetate to the tricarboxylic acid (TCA) cycle in order to replenish 
intermediates lost to competing biosynthetic pathways. Thus, PC activity directly influences the availability of 
metabolites for fatty acid and amino acid biosynthesis. Human congenital deficiencies in PC may result in severe 
lactic acidemia, improper psychomotor development, mental retardation and, sometimes, death within a few 
weeks (reviewed in [43]). These severe phenotypes can, in part, be attributed to reduced γ-aminobutyric 
acid and glutamate production, essential neurotransmitters needed for neuronal development [44]. 
Additionally, several other disease states, including type-2 diabetes and tumor proliferation, are subject to 
aberrant PC activities and/or protein levels [45], [46], [47]. 
The native, active form of PC is a tetramer. However, two distinct variants of the tetramer exist, depending on 
the source organism. For most PC enzymes, the functional domains are arranged on a single ∼1200 amino acid 
polypeptide chain with a molecular weight of ∼120–130 kDa. Four identical polypeptide chains associate 
together to form a homotetramer of ∼500 kDa that constitutes the α4 form (Fig. 2). The less common form is the 
α4β4 form (or “subunit type”), which is observed primarily in archaea [48], [49] along with some bacterial species 
such as Pseudomonas citronellolis [50], [51] and Aquifex aeolicus [52]. This tetrameric form consists of two 
distinct polypeptide chains: a ∼55 kDa polypeptide (β) chain which has MgATP-dependent biotin carboxylation 
activity and a ∼70 kDa polypeptide (α) chain which includes an N-terminal carboxyltransferase domain and a C-
terminal BCCP domain (Fig. 2). Four α and four β polypeptide chains associate together to form an active 
heterooctamer. To date, structural studies of the α4β4 PC enzymes have been limited. However, the quaternary 
configuration of the α4β4 PC enzyme from P. citronellolis is proposed to be similar to that of α4 type PC 
enzymes [50]. 
The first X-ray crystal structure of a complete biotin-dependent enzyme was reported for the α4-type PC 
from Rhizobium etli [53]. The R. etli PC structure was closely followed by the report of the holoenzyme structure 
of PC from Staphylococcus aureus [54]. Together, these X-ray analyses unveiled the quaternary arrangement of 
PC and revealed the relative disposition of the individual catalytic domains. The monomers of the α4 PC tetramer 
are arranged on two distinct layers, running perpendicularly between the two layers and oriented antiparallel to 
each other on opposite sides of the tetramer (Fig. 4). Minimal direct contacts are observed between monomers 
located on the same layer. The tetramer is held together at the corners by BC–BC and CT–
CT dimerization interfaces. From the arrangement of the catalytic domains and analysis of mixed hybrid 
tetramers, it was determined that BCCP-biotin physically moves by ∼50–70 Å from the BC domain on one 
polypeptide chain to the carboxyltransferase domain on a neighboring polypeptide chain (Fig. 4). This initial 
model for catalysis was confirmed by additional structures that captured the BCCP domain physically interacting 
with the carboxyltransferase domain of a neighboring polypeptide chain [54], [55], [56]. These data served to 
explain the long-standing observation that PC does not exhibit pyruvate carboxylation activity in its dimeric or 
monomeric states [57], [58], [59]. 
 
Fig. 4. Quaternary structure and intermolecular reaction mechanism of pyruvate carboxylase. The PC tetramer is 
arranged in two distinct layers, with the monomers running antiparallel on each layer and perpendicularly 
between the layers. Both R. etli (pdb i.d. 2QF7) and S. aureus (pdb i.d. 3BG5) primarily associate at the dimer 
interface between the biotin carboxylase (blue) and carboxyltransferase (yellow) domains. S. aureus PC 
maintains contacts between the allosteric (green) domains from opposite layers of the tetramer. This interaction 
is not observed in RePC. For clarity and to enable comparison, the BCCP domain is omitted from the top 
illustrations of the R. etli and S. aureus PC tetramers. The bottom tetramer illustrates the translocation of the 
BCCP domain (red) between the biotin carboxylase and carboxyltransferase domain active sites on opposing 
monomers of the R. etli PC enzyme (based on pdb i.d. 2QF7). The distance between active sites of opposing 
monomers on the same face is ∼60 Å. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.) 
 
In the overall reaction catalyzed by PC, the carboxyltransferase domain catalyzes the second half-reaction. After 
the tethered biotin cofactor is carboxylated in the BC domain with the concomitant cleavage of ATP, the BCCP 
domain translocates to the carboxyltransferase domain, where the carboxyl group is transferred from 
carboxybiotin to pyruvate, forming oxaloacetate. The reaction equilibrium in PC strongly favors this forward 
reaction. However, the carboxyltransferase domain half-reaction is routinely assayed by following 
the decarboxylation of oxaloacetate, and the overall reaction can also be run in the reverse direction, starting 
with oxaloacetate, ADP and Pi [60], [61], [62], [63]. Thus, while the carboxyltransferase domain of PC normally 
catalyzes the carboxylation of pyruvate, it may also be considered a biotin-dependent oxaloacetate 
decarboxylase. 
Oxaloacetate decarboxylase complex 
In a series of papers published in the early 1980s, Peter Dimroth demonstrated that the membrane-bound 
oxaloacetate decarboxylase complex (OADC) of Klebsiella aerogenes catalyzes the biotin-dependent 
decarboxylation of oxaloacetate, while also serving as a primary Na+ pump [64], [65], [66]. OADC plays an 
essential role in the citrate or tartrate fermentation pathways of certain archaea and bacteria, contributing to 
the generation of an electrochemical gradient of Na+ ions along with one mol of ATP per mol of citrate/tartrate. 
The resulting Na+ gradient is used to power the import of nutrients and the synthesis of ATP. The structure and 
mechanism of OADC was last reviewed by Buckel [29] and by Dimroth et al. [31], both in 2001. Since then, only a 
handful of publications have focused on OADC, but several of these served to significantly advance the 
description of the structure and mechanism of this enzyme. Most notably, Studer et al. reported the X-ray 
crystal structure of the carboxyltransferase domain of OADC in 2007 [67], while, more recently, Balsera, Buey 
and Li used homology modeling and SAXS data to propose an updated model for the OADC quaternary 
structure [68]. 
OADC is typically composed of three subunits: α, β and γ Fig. 2 and Fig. 3. The ∼65 kDa hydrophilic α-subunit 
consists of an N-terminal carboxyltransferase domain connected to a C-terminal BCCP domain. The α-subunit is 
a peripheral membrane protein on the cytosolic side of the membrane, where it associates with β- and γ-
subunits that are embedded in the membrane. While the exact multimer size may vary depending on the source 
organism, the OADC complex from Vibrio cholerae is a tetramer [69] and the α:β:γ stoichiometry has long been 
assumed to be 1:1:1 based on the original analysis performed on the enzyme from K. aerogenes [70]. However, 
according to the X-ray crystal structure and solution studies, in the absence of β- or α-subunits, the γ-subunit 
forms a homodimer through a dimerization interface in the carboxyltransferase domain [67], [68] while it forms 
a larger multimeric complex in the presence of the γ-subunit, with a predicted α:β:γ stoichiometry of 4:2:2 [68]. 
The ∼45 kDa β-subunit is an integral membrane protein with nine transmembrane segments (reviewed in [31]) 
which serves to couple the decarboxylation of carboxybiotin to the translocation of Na+ from the cytoplasm to 
the periplasm. While there is no available X-ray crystal structure of this domain (nor, indeed, are there structural 
data for the complete OADC complex), the β-subunit has been subjected to extensive mutagenic analysis, with 
several key residues shown to be necessary for Na+ binding, Na+ channeling and biotin 
decarboxylation [31], [71], [72]. 
The small ∼9 kDa γ-subunit is an integral membrane protein with a single membrane-spanning helix at the N-
terminus, followed by a hydrophilic C-terminal domain which interacts with the α-subunit. The γ-subunit is 
essential for the overall stability of the complex, and likely serves as an anchor to hold the α- and β-subunits in 
place [73]. Furthermore, the γ-subunit significantly accelerates the rate of oxaloacetate decarboxylation in the 
α-subunit, and this correlates with the coordination of a Zn2+ metal ion by several residues at the hydrophilic C-
terminus [73], [74]. It was originally proposed that the γ-subunit Zn2+ metal ion inserts into the 
carboxyltransferase domain active site of the α-subunit and serves as the Lewis acid metal center to stabilize the 
pyruvate enolate (the general carboxyltransferase domain mechanism is described in detail in a later section). 
However, the crystal structure of the carboxyltransferase domain from the α-subunit of V. cholera OADC 
revealed that the Zn2+ metal responsible for stabilization of the pyruvate enolate is bound within the 
carboxyltransferase domain itself and does not require the insertion of Zn2+ from the γ-subunit [67]. Instead, the 
site of interaction with the γ-subunit in V. cholerae OADC has been shown to be located in an intervening region 
between the carboxyltransferase and BCCP domains of the α-subunit, termed the “association domain” [75] (Fig. 
5). This association domain resembles the allosteric/tetramerization domain of PC [68]. 
 
Fig. 5. A simplified model of the oxaloacetate decarboxylase complex structure. Oxaloacetate decarboxylase is 
composed of three separate subunits: the α-subunit (illustrated as a three-dimensional protein structure), the β-
subunit (illustrated as a cartoon, colored in white) and the γ-subunit (illustrated as a cartoon, colored in blue). 
The γ-subunit is composed of a single membrane-spanning helix at the N-terminus (illustrated as a blue 
transmembrane cylinder) followed by a hydrophilic C-terminal domain (illustrated by dashed lines and a single 
α-helix) that interacts with the association domain of the α-subunit of monomer A (colored in green). The α-
subunit is composed of an N-terminal carboxyltransferase domain dimer (monomer A is colored yellow; 
monomer B is colored orange) and a C-terminal BCCP domain of monomer A (colored red). The arrows illustrate 
a hypothetical path traversed by the BCCP domain as it transits from the carboxyltransferase domain active site 
to the β-subunit. Carboxybiotin is decarboxylated in the β-subunit, resulting in the transport of Na+ ions out of 
the cytosol. A more sophisticated model for BCCP translocation has recently been proposed, where the BCCP 
domain moves from the carboxyltransferase domain of one OADC complex to the β-subunit of a neighboring 
complex [68]. This illustration is based on the β-subunit topology determined by Dimroth (reviewed in [31]), the 
X-ray crystal structure of the carboxyltransferase domain of OADC (pdb i.d. = 2NX9; [67]) and the model for α/γ 
subunit interactions proposed by Balsera, Buey and Li [68]. The allosteric and BCCP domains are taken from the 
structure of R. etli PC (pdb i.d. = 2QF7) and are oriented according to a superimposition of the R. etli PC and 
OADC carboxyltransferase domains. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.) 
 
The overall reaction catalyzed by OADC couples the decarboxylation of oxaloacetate to the exchange of two 
intracellular Na+ ions for one extracellular H+ ion. The reaction is initiated by the enzyme-catalyzed 
decarboxylation of oxaloacetate in the carboxyltransferase domain of the α-subunit, yielding pyruvate and 
carboxybiotin. Subsequently, the C-terminal BCCP domain on the α-subunit translocates to the β-subunit where 
its decarboxylation is coupled to Na+ translocation. As with PC, the OADC pump is reversible: at high 
concentrations of extracellular Na+, the pump will couple the downhill movement of Na+ into the cytosol with 
the carboxylation of pyruvate, to form oxaloacetate [76]. The biochemistry of OADC has been extensively 
studied and the mechanism of biotin decarboxylation and Na+ translocation in the β-subunit has been 
comprehensively reviewed [31]. 
Transcarboxylase 
Transcarboxylase (TC) plays a key role in the fermentation of malic and lactic acids by propionic acid bacteria, 
with propionic and acetic acids serving as the major end-products. Swick and Wood were the first to identify a 
biotin-dependent transcarboxylase activity in the cell-free extracts of the propionic-acid bacterium P. 
shermanii and showed that methylmalonyl CoA and pyruvate were the substrates for the reaction (Fig. 
3; [77]). Harland Wood made monumental contributions to the study of biotin-dependent enzymes through his 
work on TC. Not long after his initial discovery of the enzyme, he purified the biotinylated enzyme [34] and, 
following several years of intense study, he showed that the enzyme was comprised of three distinct subunits: a 
1.3S subunit that serves as the biotin carboxyl carrier protein, a 12S subunit that catalyzes the first half reaction 
(the decarboxylation of methylmalonyl-CoA to propionyl-CoA with formation of carboxybiotin) and a 5S subunit 
that catalyzes the second half reaction (the carboxylation of pyruvate to oxaloacetate) (Fig. 3; [78]). The 
complete enzyme consists of a hexameric central core of 12S subunits surrounded by six 5S dimers, each 
connected to the central core by twelve 1.3S biotin carrier subunits (reviewed in [79]). The structure is expected 
to be similar to the architecture observed in the recently reported holoenzyme structures of propionyl-CoA 
carboxylase and methylmalonyl-CoA carboxylase, where a central hexameric core is capped on each end by 
three α-subunits containing the carboxyltransferase and BCCP domains [80], [81]. In the forward direction, the 
overall reaction involves the conversion of methylmalonyl-CoA and pyruvate to propionyl-CoA and oxaloacetate. 
As was often emphasized by Wood in his many publications on the subject, TC is unique among the biotin-
dependent enzymes in that CO2 plays no role in the reaction, either as a substrate or a product. 
More recently, Yee and colleagues reported the X-ray crystal structures of the 5S and 12S subunits providing, in 
the case of the 5S subunit, the first structure of a carboxyltransferase domain with biotin-dependent 
oxaloacetate decarboxylase activity [82], [83]. In a 2004 review, Carey, Sönnichsen and Yee elegantly 
summarized these structural advances in the context of Harland Wood’s earlier pioneering work [84]. Since 
then, however, few studies on TC have been reported. Bhat and Berger showed by NMR that free biotin 
interacts with the carboxyltransferase domain of the 5S subunit and that biotin and pyruvate occupy different 
binding sites [85], results that are consistent with X-ray crystal structures reported for the carboxyltransferase 
domain of PC [54]. 
The carboxyltransferase domains of TC and PC are functionally very similar. Both enzymes catalyze an identical 
reaction in the second partial reaction, namely the transfer of a carboxyl group from a covalently tethered 
carboxybiotin to pyruvate to generate oxaloacetate. While the TC reaction is typically drawn in the forward 
direction, the reaction is freely reversible and the carboxyltransferase domain is equally capable of catalyzing 
the decarboxylation of oxaloacetate (see, for example, [86]). As is the case with PC, therefore, it may also be 
considered a biotin-dependent oxaloacetate decarboxylase. 
Carboxyltransferase domain structure 
Recent X-ray crystal structures of PC [53], [54], [55], [62], the carboxyltransferase domain of the α-subunit of 
OADC (α-OADC) [67] and the 5S subunit of TC [83] have greatly advanced the description of catalysis in these 
enzymes. The carboxyltransferase domains from all three of these enzymes are homologous. The domain 
from P. shermanii 5S TC is 33% identical to human PC and the α-carbon atoms superimpose with a root-mean-
square deviation of 1.4 Å. Similarly, the carboxyltransferase domain of α-OADC from V. cholerae is 34% identical 
to human PC and the α-carbon atoms correspond with a root-mean-square deviation of 1.3 Å. In all three cases, 
the carboxyltransferase domain crystallizes as a homodimer, in accordance with the dimerization state observed 
in solution. The active site architectures are virtually identical, suggesting that they share a common mechanism 
for stabilizing the pyruvate enolate. 
The carboxyltransferase domain of the biotin-dependent oxaloacetate decarboxylases can be grouped into a 
larger family of TIM barrel metalloenzymes, called the “DRE-TIM” family, that catalyze carbon–carbon bond 
cleavage reactions proceeding through a stabilized enolate intermediate [87]. The overall domain architecture 
consists of two subdomains: an N-terminal canonical (β/α)8 TIM barrel fold and a large C-terminal extension, 
composed of nine α-helices (Fig. 6a). The C-terminal subdomain forms a funnel leading into the active site at the 
mouth of the (β/α)8 barrel. Structures of 5sTC, α-OADC, and PC all reveal a divalent metal cation bound in the 
active site (Zn2+, Mn2+ or Co2+), chelated by two conserved histidine residues (HxH) and a conserved aspartate 
(Fig. 6b). In some structures, but not all, the metal ion is further coordinated by the carboxylate oxygens of a 
carbamylated lysine residue [53], [54], [62], [83], [88]. A possible role for this carbamylated lysine in the catalytic 
mechanism is discussed below. 
 
Fig. 6. The carboxyltransferase domain of pyruvate carboxylase. (a) A stereoview of a representative 
carboxyltransferase domain homodimer from Rhizobium etli PC (pdb i.d. = 2QF7). The carboxyltransferase 
domain is a homodimer consisting of a canonical (β/α)8 TIM barrel fold (blue) capped by a nine-helix C-
terminal funnel (green). (b) The carboxytransferase active site centers on a divalent cation coordinated by a 
conserved pair of His residues (HxH) and a conserved Asp, with a carbamylated Lys (labeled KCX) coordinating 
the metal ion in some structures, as shown for the active site of R. etli PC (pdb i.d. = 2QF7). (c) A stereoview 
highlighting substrates and important residues in the carboxyltransferase active site of human PC. 
Tethered biotin (BTN; orange) is bound in the active site of human PC (pdb id = 3BG3), with the N-1 nitrogen 
positioned 4.5 Å from the β-carbon of pyruvate (PYR). A conserved Thr residue (T908 in human PC) serves to 
shuttle a proton between biotin and pyruvate. (For interpretation of the references to color in this figure legend, 
the reader is referred to the web version of this article.) 
 
In PC enzymes, the identity of the tightly bound metal ion is species-specific. Vertebrates predominantly bind 
Mn2+, whereas yeast and bacteria prefer Zn2+ [37]. On the other hand, the 5S subunit of TC primarily binds 
Co2+ in its active site [83], but there is also evidence for Zn2+ binding [89], [90]. α-OADC purified from source 
binds Zn2+ exclusively, but can also bind Co2+ when heterologously expressed in E. coli [67]. It is clear that the 
metal ion in the carboxyltransferase domain plays an important functional role in all three enzymes. Mutating 
the metal-chelating aspartate in PC from Bacillus thermodenitrificans results in a 22-fold reduction in 
pyruvate carboxylation activity and a 54-fold increase in KM for pyruvate [91]. In the carboxyltransferase domain 
of OADC from V. cholerae, mutations in either the aspartate or the two histidine residues that coordinate the 
active site metal results in a complete loss of enzyme activity. Mutating the conserved metal-chelating lysine 
either substantially reduces or completely eliminates enzyme activity in all three 
enzymes [53], [61], [67], [83], [91]. In addition, the physical removal of the tightly bound metal in TC [89], 
PC [92] and OADC [93] causes aggregation and enzyme dissociation, suggesting that the metal ion plays a critical 
role in maintaining the structural integrity of the enzyme. 
Oxaloacetate decarboxylation mechanism 
Well before the structure of the carboxyltransferase domain was known, three central mechanistic features 
were established through studies conducted on both PC and TC: (1) the carboxylation of pyruvate to 
oxaloacetate proceeds with retention of configuration at the carbon atom undergoing carboxylation [94], [95]; 
(2) the reaction proceeds by a stepwise mechanism [96], [97]; (3) in PC, carboxybiotin does not translocate to 
the carboxyltransferase domain before pyruvate or a pyruvate analog binds in the active site [98], [99], [100]. 
While major structural advances in recent years have considerably advanced the description of catalysis in the 
carboxyltransferase domain, the mechanistic details have remained consistent with these earlier observations. 
The biotin-dependent decarboxylation reaction in the carboxyltransferase domain of PC, OADC and TC follows a 
stepwise mechanism that proceeds through both a stabilized enolpyruvate intermediate and a biotin enolate 
intermediate (Fig. 7). Since most of the recent advances in describing the chemical mechanism of the 
carboxyltransferase domain have come from studies on PC, this enzyme will be highlighted. However, wherever 
possible, the conclusions are extended to the broader context of all three biotin-dependent oxaloacetate 
decarboxylase enzymes. 
 
Fig. 7. The pyruvate carboxylation mechanism for the carboxyltransferase domain of R. etli pyruvate 
carboxylase. This research was originally published in The Journal of Biological Chemistry. Adam Lietzan and 
Martin St. Maurice. A Substrate-induced Biotin Binding Pocket in the carboxyltransferase Domain of Pyruvate 
Carboxylase. J. Biol. Chem. 2013; 288: 19,915–19,925. 
Copyright © 2013 The American Society for Biochemistry and Molecular Biology. 
 
Stabilization of the enolpyruvate intermediate 
Prior to determination of the X-ray structures of the carboxyltransferase domain, it was well established that a 
tightly bound divalent metal ion was essential for activity in TC, OADC and PC and that the pyruvate binding site 
in PC was located near this metal ion [89], [93], [101], [102], [103]. Since then, several structures have revealed 
substrates or substrate analogs bound near the active site metal ion in the carboxyltransferase domain of both 
PC and TC [54], [62], [83], [104]. Given the proximity of substrates and substrate analogs to the divalent cation, 
it has been proposed that the metal ion serves to stabilize the enolpyruvate intermediate that is generated 
following the decarboxylation of oxaloacetate [54], [61], [67]. However, while the metal ion is often illustrated in 
reaction schemes as forming a bidentate interaction with the β-keto acid substrate, there is, as yet, no structural 
evidence to support a direct interaction between the substrate and the metal ion [104]. 
Yee and coworkers were the first to suggest that the metal ion does not directly participate in stabilizing the 
pyruvate enolate but serves, instead, to bind and orient the substrate [83]. Many substrate-bound 
carboxyltransferase domain structures have since been reported for PC and, in all cases, the carbonyl oxygen of 
substrate and substrate/product analogs resides at a greater distance (>3.5 Å) from the metal ion than would be 
expected from direct chelation [54], [62], [104]. In all carboxyltransferase domain structures, a conserved 
glutamine/arginine pair (RXXXQ; Arg571/Gln575 in human PC) is positioned in close proximity to the carbonyl 
oxygen of the substrate (Fig. 6c). These residues may provide sufficient stabilization to the enolpyruvate 
intermediate that a direct interaction with the metal ion is unnecessary for catalysis. Notably, the 
glutamine/arginine pair (Arg571/Gln575 in human PC) is conserved in the broader DRE-TIM metalloenzyme family 
that catalyzes carbon–carbon bond cleavage on substrates that proceed through stabilization of an enolate 
intermediate [87]. Mutation of the Arg/Gln pair in R. etli PC (Arg548 and Gln552) results in substantially reduced 
stabilization of the enolate intermediate without significantly perturbing substrate binding [105]. Furthermore, 
mutating the analogous arginine and glutamine residues in OADC completely eliminates enzyme activity [67]. 
The structures of R. etli, S. aureus, and human PC with bound substrate and substrate/product analogs identified 
an additional conserved active site arginine (Arg644 in human PC; Fig. 6c) that forms a salt bridge with the 
carboxylate group of pyruvate [54], [62], [104]. Mutating the equivalent arginine in S. aureus PC eliminates 
pyruvate carboxylation activity [55]. This residue is only conserved within the homologous carboxyltransferase 
domains from the biotin-dependent oxaloacetate decarboxylases and not in the broader DRE-TIM family, 
suggesting that it is specifically positioned to interact with and orient the pyruvate/oxaloacetate substrate. 
Structures of the carboxyltransferase domain from several PC enzymes, OADC and TC have revealed substantial 
variation in the degree of carbamylation of a conserved lysine residue positioned within the coordination sphere 
of the active site metal ion (see KCX in Fig. 6b and c). This residue appears to primarily contribute to 
coordination of the metal ion, since it is always observed interacting with the metal ion regardless of its 
carbamylation state in all PC enzyme structures. However, in the structure of P. shermanii 5S TC, the lysine side 
chain is carbamylated in the apo enzyme, is partially carbamylated in the pyruvate bound state, and is not 
carbamylated when oxaloacetate is bound [83]. These observations led Hall et al. and Studer et al. to propose 
that the carbamylated lysine serves as a carboxylate carrier between oxaloacetate and carboxybiotin [67], [83]. 
Mutation of the carbamylated lysine in both 5S TC and α-OADC leads to a complete loss of enzyme activity, 
consistent with this hypothesis [67], [83]. More recent structural and kinetic data from PC, however, raise 
questions about the universality of this proposed mechanism. For example, mutations of this lysine residue in B. 
thermodenitrificans PC [91] and R. etli PC [53], [61] maintain 1–5% of wild type activity, indicating that, while this 
residue is important, it is not essential for PC catalysis. Furthermore, the structures of S. aureus and human PC 
with bound BCCP-biotin reveal that 1’-N of biotin is located ∼8 Å from the carbamylated lysine residue (Fig. 6c), 
precluding any possibility of direct transfer. Since there is, as yet, no structure of 5S TC or α-OADC with biotin 
bound in the active site, it is unclear whether these homologous enzymes use different mechanisms for 
carboxylate transfer or whether the role of the carbamylated lysine residue in 5S TC and α-OADC has been 
misinterpreted. 
Carboxyl group transfer to biotin and stabilization of the biotin enolate intermediate 
The role of biotin in the pyruvate/oxaloacetate carboxyltransfer reaction has been greatly informed by the 
structures of the S. aureus and human PC that revealed a tethered biotin bound in the carboxyltransferase 
domain active site ∼5 Å removed from the β-carbon of pyruvate, a distance too great for direct proton/carboxyl 
transfer between substrates [54]. The ureido oxygen of biotin is positioned in close proximity to a 
conserved serine side chain and adjacent backbone amide group (e.g. Ser911 and Lys912 in human PC; Fig. 6c), 
located in the C-terminal subdomain funnel of all biotin-dependent oxaloacetate decarboxylases. In addition, a 
glutamine side chain from helix 10 (Gln870 in human PC; Fig. 6c) projects toward the ureido oxygen of biotin in 
PC, but this residue is not conserved in α-OADC or 5S TC. Interestingly, helix 10 represents a rare case of modest 
structural deviation between PC, OADC and TC: this helix originates from deeper within the active site cavity in 
PC than do the equivalent helices in OADC or 5S TC. It has been proposed that the serine and glutamine side-
chains, together with the backbone amide nitrogen, contribute to a tetrahedral geometry near the biotin ureido 
oxygen that likely serves to facilitate the decarboxylation of biotin by stabilizing the negative charge on 
the sp3 oxyanion of the biotin enolate intermediate [54], [61]. In the existing PC crystal structures, the ureido 
oxygen of biotin is located near this tetrahedral coordination sphere but is not centered within it. However, the 
bulkier carboxybiotin substrate is likely to occupy a slightly altered position in the binding site that may result in 
centering the ureido oxygen for maximum stabilization. While these residues have not been subjected 
to mutagenesis in TC or OADC, mutation of the glutamine and serine side chains in PC leads to a reduced rate of 
oxaloacetate decarboxylation, which is proposed to result from a weakened stabilization of the biotin enolate in 
the rate-limiting biotin decarboxylation step [61]. 
The carboxyltransfer reaction between oxaloacetate and biotin has been most extensively studied in PC. A pH 
rate profile of the oxaloacetate decarboxylation reaction revealed no ionizable groups, leading Attwood and 
Cleland to propose that direct proton transfer occurs between pyruvate and biotin, and that this step follows 
the initial decarboxylation of carboxybiotin (forward) or oxaloacetate (reverse) [60]. Deuterium isotope and 13C 
isotope effects have also been observed in PC, indicating that both proton and carboxylate transfer are partially 
rate limiting and that there are separate proton and carboxylate transfer steps in the reaction [96], [106]. 
Stepwise transfer has also been reported in TC [97]. Most recently, structural and site-directed mutagenic 
studies have unveiled a critical role for a conserved threonine side chain, positioned between the N-1’ of biotin 
and the β-carbon of pyruvate in PC and ideally poised to bridge the ∼5 Å gap between these two substrates (Fig. 
6c). This threonine side chain, conserved in all three biotin-dependent oxaloacetate decarboxylase enzymes, 
shuttles a proton between the enolates of biotin and pyruvate and is indispensable for catalysis (Fig. 
7) [54], [61]. The threonine side chain rests at the base of the C-terminal extension funnel of the 
carboxyltransferase domain. While the threonine residue responsible for proton shuttling is present in all three 
enzymes, to our knowledge, this residue has not yet been subjected to mutagenic analysis in either TC or OADC. 
We predict that such studies would confirm a common proton shuttling mechanism associated with carboxyl 
transfer in the biotin-dependent oxaloacetate decarboxylases and would also confirm that a common biotin 
binding site is present in all three enzymes. Consistent with this prediction, Bhat and Berger recently showed 
that biotin and pyruvate occupy different binding sites in TC [85], suggesting that biotin and pyruvate are 
separated in TC just as they are in PC. 
The most recent description of the chemical mechanism for carboxyl group transfer between oxaloacetate and 
biotin is summarized using the specific example of R. etli PC in Fig. 7. In PC and TC, this reaction is typically 
drawn proceeding in the direction of pyruvate carboxylation. The reaction is freely reversible, however, and 
proceeds in the opposite direction for oxaloacetate decarboxylation. Carboxybiotin, tethered to BCCP, enters 
the active site after pyruvate binds (described in greater detail below). Once bound, carboxybiotin 
decarboxylation is promoted through biotin enolate stabilization in the conserved active site triad and, 
potentially, through a proposed rotation of the carboxyl group out of plane with the ureido ring [107]. A proton 
is subsequently shuttled from pyruvate to the biotin enolate via the conserved threonine residue, forming an 
enolpyruvate intermediate. Finally, the previously liberated CO2 is transferred to pyruvate, generating 
oxaloacetate. The stabilization of the enolpyruvate intermediate by conserved active site residues and possibly 
the tightly bound metal ion serves to increase the acidity of the methyl group protons and facilitate proton 
abstraction by the conserved threonine. 
It is noteworthy that nine disease-causing single nucleotide substitutions have been identified in human 
PC [108]. Of these, four (R583L, A610T, R631Q and M743I) have been mapped to the carboxyltransferase 
domain and the residues are conserved in all three biotin-dependent oxaloacetate decarboxylase enzymes. The 
A610T mutation is located at the opening of the active site. The bulkier threonine partially precludes the binding 
of biotin in the active site, thus greatly reducing enzyme activity [55], [83]. The M743I is located deep in the 
active site where it most likely disrupts pyruvate binding [54], [83]. The R583L and R631Q mutations are located 
at the surface of the CT domain, distant from the active site. It has been proposed that these mutations may 
induce a conformational change that alters the interaction between domains and interferes with the 
transmission of the regulatory signal from acetyl-CoA [108]. 
Interaction between the CT and BCCP domains 
Whereas the detailed chemical mechanism for biotin-dependent carboxyl transfer now appears well-resolved, 
there are many remaining questions surrounding the interaction between the BCCP and carboxyltransferase 
domains and how these inter-domain interactions contribute, if at all, to the coordination of catalysis that exists 
between physically separate active sites. Structural insights in this regard are limited to PC, since X-ray crystal 
structures have not yet been reported for the combined BCCP and carboxyltransferase domains in either TC or 
OADC. 
The S. aureus PC and human PC structures afforded the first snapshots of the BCCP-carboxyltransferase domain 
interaction [54]. In these structures, the BCCP domain is captured binding in the C-terminal funnel of the 
carboxyltransferase domain with the biotinylated MKME hairpin extending deeply into the funnel, 
allowing biotin to reach into the active site (Fig. 6c). In response to the docking of the BCCP domain, several α-
helices (most notably, helix 10) in the C-terminal funnel shift inwards to create a more “closed” conformation. 
This may allow the binding of BCCP to transmit an effect into the active site through the changes in the relative 
positioning of the tethered biotin, the threonine, and the pyruvate/oxaloacetate substrate. Aside from this 
general set of movements, however, very few specific side chain interactions are observed between BCCP and 
CT [54]. This lack of specific interactions is not surprising given that the BCCP domain must freely translocate 
between individual catalytic domains. A similar paucity of specific inter-domain interactions with BCCP has been 
repeatedly observed in the holoenzyme structures of other biotin-dependent enzymes [80], [81], [88], [109]. 
The dependence of oxaloacetate decarboxylation on BCCP-biotin remains to be established. While it appears 
that the 5S TC subunit is unable to catalyze oxaloacetate decarboxylation in the absence of an intact BCCP 
domain [110], there are several reports in the PC literature suggesting that the enzyme can catalyze 
oxaloacetate decarboxylation in the absence of BCCP-biotin, albeit at a greatly reduced 
rate [60], [62], [105], [111], [112]. To our knowledge, similar studies have not yet been performed in α-OADC. It 
is certainly possible to envision oxaloacetate decarboxylation proceeding in a biotin-independent manner, in a 
reaction similar to what has been proposed for the non-homologous oxaloacetate decarboxylase PA4872 
from Pseudomonas putida, where a water molecule is thought to serve as the acid that donates a proton to the 
pyruvate enolate [113]. The crystal structure of the carboxyltransferase domain from R. etli PC with pyruvate 
(pdb i.d. 4JX5) contains several ordered water molecules in the active site [62]. Furthermore, the pKa of water 
(15.7) is less than the pKa for the N-1 of biotin (∼17 [11]), making it an equivalent proton donor, provided that 
the hydrogen-bonding network in the active site can stabilize the hydroxide ion in a similar manner to the biotin 
enolate. The stabilized hydroxide will subsequently react with the liberated CO2 to form bicarbonate, completing 
the reaction cycle. Further studies are warranted to determine the degree to which both biotin and BCCP 
contribute to the catalytic rate in the carboxyltransferase domain of these enzymes. 
A major unanswered question surrounding the biotin-dependent enzymes is centered on the mechanism 
responsible for the coordination and control of BCCP access to the individual active sites during catalytic 
turnover. For example, Goodall et al. showed for sheep liver PC that N-[14C]-carboxybiotin is quite stable in the 
absence of substrates, but that several carboxyltransferase domain substrates and competitive inhibitors of 
pyruvate are sufficient to invoke the translocation and decarboxylation of N-[14C]-carboxybiotin in the 
carboxyltransferase domain [98]. These experiments demonstrated that carboxybiotin rapidly decarboxylates in 
the carboxyltransferase domain, even in the absence of the bona fide acceptor substrate, and that a 
carboxyltransferase domain ligand is required to facilitate BCCP-biotin access to the active site. Recently, we 
described a substrate-induced biotin binding pocket in the carboxyltransferase domain of R. etli PC that provides 
a structural explanation for the phenomenon described by Goodall et al. [62]. Structures of the R. 
etli carboxyltransferase domain, in the presence and absence of substrates and substrate analogs, reveal that 
the biotin binding site in the carboxyltransferase domain forms as a consequence of pyruvate binding in the 
active site. The active site is reconfigured upon pyruvate binding, from an “open” conformation to a “closed” 
conformation (Fig. 8). This conformational rearrangement is initiated by the interaction of the substrate 
carboxylate with the conserved active site arginine mentioned previously (Arg644 in human PC; Fig. 6c) and is 
stabilized by the interaction of a conserved aspartate and tyrosine residue (e.g. Asp590 and Tyr628 in R. etli PC), 
resulting in the formation of the biotin-binding pocket. Both the tyrosine and aspartate residues are conserved 
in OADC and TC, suggesting that a common mechanism extends across all of the biotin-dependent oxaloacetate 
decarboxylase enzymes. Interestingly, the X-ray crystal structure of the carboxyltransferase domain from V. 
cholera OADC also displays an open conformation in the absence of bound substrate [67] and both fluorescence 
and infrared data demonstrate that ligand binding restricts the tryptophan microenvironment and promotes 
structural changes in the carboxyltransferase domain of OADC [114] consistent with what is observed in the 
structures of PC. 
 
Fig. 8. Substrate binding leads to active site remodeling in the carboxyltransferase (CT) domain of RePC. (a). 
Stereo view of the active site from the carboxyltransferase domain upon pyruvate binding, showing the change 
from the open conformation (orange) to the closed conformation (cyan) following substrate binding. The 
positioning of the orange loop is from the X-ray crystal structure devoid of pyruvate. Pyruvate is colored green. 
The multiple conformations for Arg621 were modeled from RePC wild-type (pdb i.d. 2QF7). (b) Structural 
alignment of the pyruvate-bound ΔBCΔBCCP RePC with the HsPC crystal structure (pdb i.d. 3BG3; monomer B; 
r.m.s. deviation = 1.3 Å) reveals the expected positioning of biotin in the carboxyltransferase domain active site 
of RePC. In the closed conformation, Asp590 and Tyr628 form a surface to assist with biotin insertion into the 
active site. This research was originally published in The Journal of Biological Chemistry. Adam Lietzan and 
Martin St. Maurice. A Substrate-induced Biotin Binding Pocket in the carboxyltransferase domain of pyruvate 
carboxylase. J. Biol. Chem. 2013; 288: 19,915–19,925. 
Copyright © 2013 The American Society for Biochemistry and Molecular Biology. 
 
Allosteric/tetramerization domain of PC and the association domain of OADC 
While not directly part of the carboxyltransferase domain, a final section of this review is devoted to the 
similarities in a small structural domain that neighbors the carboxyltransferase domain in both OADC and PC. 
Most α4 forms of PC are subject to regulation by the non-essential, allosteric activator acetyl-coenzyme A, which 
enhances pyruvate carboxylation activity and stabilizes the tetramer (reviewed in [115]). The holoenzyme 
structures of α4 PC from R. etli and S. aureus, along with the structure of the biotin carboxylase domain 
truncation of α4 human PC, revealed a structural domain linking the biotin carboxylase, CT and BCCP domains 
(Fig. 4, green) [53], [54]. This small domain, termed the “allosteric” domain in R. etli PC and the “PC 
tetramerization” domain in S. aureus and human PC, consists of a central helix that connects the biotin 
carboxylase and carboxyltransferase domains. It is surrounded by a highly-twisted, four-stranded anti-parallel β-
sheet that links the C-terminus of the carboxyltransferase domain to the BCCP domain. 
This domain appears to play multiple roles in PC. Most notably, it serves as the binding site for 
the nucleotide moiety of the allosteric activator, acetyl-CoA [53], [55]. A mutation in Arg451 (R451C), located in 
close proximity to the acetyl-CoA binding site, is associated with human PC deficiency. This R451C mutation was 
kinetically characterized and was shown to significantly reduce the sensitivity of PC to acetyl-CoA activation [54]. 
In addition to serving as the acetyl-CoA binding site, the allosteric domain in S. aureus and human PC is 
necessary for tetramerization, forming homodimer contacts across the face of the tetramer [54], [55]. Finally, 
structures of S. aureus and R. etli pyruvate carboxylases have revealed a biotin binding pocket, termed the exo-
binding site, at the interface between the allosteric domain and the carboxyltransferase domain [41], [54]. This 
exo-binding site was not observed in the structure of human PC, where a conformational change in a C-terminal 
loop precluded access to the site [54]. It is not known what role, if any, the exo-binding site plays in the overall 
reaction catalyzed by PC. 
Balsera et al. [68] recently reported the stoichiometry and SAXS-based structure of the soluble α-subunit and 
the cytosolic portion of the γ-subunit (termed γ′) from V. cholera OADC. Their results suggest that 
tetramerization of α-OADC is mediated by an interaction between the “association domain” of the α-subunit 
and γ′-subunit in a manner that is completely analogous to the allosteric domain of PC. In an intriguing model, it 
was proposed that BCCP-biotin is carboxylated in the carboxyltransferase domain of a neighboring α-OADC. The 
interaction is facilitated by the tetramerization of α-OADC through interactions between the association domain 
and the γ′-subunit, which maintain two of the four α-OADC molecules in close proximity to the membrane-
bound β-subunit. This proposal is consistent with the observed subunit stoichiometry and invokes a half-the-
sites-reactivity model similar to what has been suggested for other biotin-dependent enzymes. Most 
interestingly, the γ′-subunit appears to stabilize a four-stranded β-sandwich in the association domain of the α-
subunit that is proposed to act analogously to the central α-helix of the allosteric domain in PC. 
It is tempting to use the observations in OADC and PC to speculate about inter-subunit association in TC, where 
the ∼50 amino acid N-terminal tail of the 1.3S subunit is required for attachment to the 5S and 12S 
subunits [116]. The structure of the N-terminus of the isolated 1.3S subunit was highly disordered and could not 
be determined by NMR [117]. Given that elements of the PC allosteric domain have now been observed in PC, 
OADC, propionyl-CoA carboxylase and 3-methylcrotonyl-CoA carboxylase, it is conceivable that the disordered 
N-terminal domain of the 1.3S subunit takes on a fold similar to the allosteric domain of PC and associates with 
neighboring subunits in a manner analogous to the γ-/association domain interaction of OADC. 
Summary 
Nearly a decade ago, Yee and colleagues reported the first structures of the carboxyltransferase domain from 
the 5S subunit of transcarboxylase. This marked the first of many major structural advances in the biotin-
dependent enzyme family that followed, a few years later, with the structures of both oxaloacetate 
decarboxylase and pyruvate carboxylase. This wealth of structural information has led to detailed mutagenic 
studies in the carboxyltransferase domains of all three biotin-dependent oxaloacetate decarboxylases and has 
revealed what appear to be many common mechanistic features across all three enzymes. Nevertheless, many 
questions remain unresolved, particularly with respect to the mechanism of carboxyl group transfer 
between biotin and oxaloacetate. The role of the carbamylated lysine in the carboxyl transfer reaction remains 
ambiguous and there are insufficient studies to determine whether these three enzymes maintain a common set 
of interactions between the biotin carrier protein and the carboxyltransferase domain. The conservation in 
structure and mechanism serves as a reminder that studies conducted in one enzyme should serve to prompt 
parallel studies in the homologous enzymes. As studies of these enzymes continue to emerge, it will become 
increasingly possible to delineate the similarities and differences within this subset of biotin-dependent 
enzymes, and from this, to extend these findings to more general conclusions about the biotin-dependent 
enzyme family as a whole. 
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